等待开盘 05-19 09:30:00 美东时间
-0.220
-8.37%
Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 14.29 percent increase over losses of $(0.14) per share
05-12 19:21
The latest announcement is out from Ovid Therapeutics ( ($OVID) ). On April 17,...
04-20 20:52
今日重点评级关注:Ascendiant Capital:维持Knightscope"买入"评级,目标价从25美元升至26美元;杰富瑞:维持Allogene疗法"买入"评级,目标价从6美元升至10美元
04-16 10:14
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从13美元升至13.5美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从8.25美元升至9美元
04-10 18:27
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and raises the price target from $2 to $4.
04-09 19:32
ALHC飙升16%,公司受益于CMS提高医疗保险支付额;潘兴广场拟高溢价收购环球音乐集团,UNVGY大涨13%;赫兹租车升逾10%,二手车价格上涨提升其车队投资回报率>>
04-08 19:09
今日重点评级关注:瑞穗:维持RELMADA THERAPEUTICS"跑赢大市"评级,目标价从10美元升至19美元;奥本海默:维持Pelthos Therapeutics"跑赢大市"评级,目标价从60美元升至62美元
03-23 13:53
踩中“AI+无人机+军工”多重风口!Swarmer上市两日狂涨1000%!全球LNG命脉被炸,天然气概念股触控科技大涨16%,Venture涨涨超14%>>
03-19 18:49